30 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon in a $1.9 billion all-cash deal.
53 Biggest Movers From Friday
Gainers
Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform.
Mid-Afternoon Market Update: Crude Oil Down 1%; MongoDB Shares Jump After Q2 Results
Toward the end of trading Friday, the Dow traded down 0.11% to 35,403.67 while the NASDAQ rose 0.23% to 15,366.71. The S&P also rose, gaining 0.04% to 4,538.92.
Mid-Day Market Update: Gold Rises 1%; Forte Biosciences Shares Plunge
Midway through trading Friday, the Dow traded down 0.23% to 35,361.40 while the NASDAQ rose 0.02% to 15,333.95. The S&P also fell, dropping 0.22% to 4,527.17.
Why Sphere 3D Shares Are Trading Lower Today
Sphere 3D Corp (NASDAQ: ANY) is trading significantly lower Friday after the company announced it entered into a securities purchase agreement with institutional investors to purchase $192.1 million of its common shares and warrants in a registered direct offering priced at-the-market.
Mid-Morning Market Update: Markets Mostly Lower; US Economy Adds 235,000 Jobs In August
Following the market opening Friday, the Dow traded down 0.41% to 35,300.08 while the NASDAQ rose 0.02% to 15,334.73. The S&P also fell, dropping 0.25% to 4,525.66.
Benzinga Pro’s Top 5 Stocks To Watch For Friday, Sept. 3, 2021: LULU, ROKU, ANY, APOP, IPHA
Today's 5 Stock Ideas:
Lululemon Athletica (LULU) - The company reports Q2 earnings Wednesday, September 8th.
Roku (ROKU) - Shares down ~2.84% premarket. There are reports that Amazon will launch
Sphere 3D Shares Dive On Discounted Equity Offering To Fund Crypto Mining
Data management firm Sphere 3D Corp (NASDAQ:ANY) agreed to raise $192.1 million by selling 22.6 million shares and warrants to purchase 11.3…
20 Stocks Moving in Friday’s Pre-Market Session
Gainers
Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 59.5% to $8.77 in pre-market trading after the company announced the ApoGraft bone marrow transplantation of the first patient in the US.